Episode Details

Domo’s stock is cratering, down 66% in six months to just $2.90, but the real story’s in the fundamentals: billings barely growing at 1% year-over-year, revenue forecasts shrinking, and slower ROI on sales efforts. Analysts warn it’s not a buy — the business is struggling, and the cheap price doesn’t fix shaky growth. Skip the falling knife and chase stocks with real acceleration instead.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/f0536a8dc8ccd7a7